Thiotepa

NDC 72205-046 · Novadoz Pharmaceuticals LLC

Generic nameThiotepa

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRACAVITARY, INTRAVENOUS, INTRAVESICAL

Active ingredient(s)THIOTEPA

Strength100 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

72205-046-01 — 1 VIAL, GLASS in 1 BOX (72205-046-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

J9342 — Injection, thiotepa, not otherwise specified, 1 mg Medicare Part B payment limit (ASP + 6%): $4.93

FDA lists these products with the same active ingredient.

0143-9292 — Thiotepa, 0143-9309 — Thiotepa, 0143-9565 — Thiotepa, 25021-246 — Thiotepa, 43598-171 — Thiotepa, 43598-650 — Thiotepa, 65219-029 — Thiotepa, 68083-446 — Thiotepa, 68083-503 — Thiotepa, 70121-1630 — THIOTEPA, 70121-1631 — THIOTEPA, 70121-1687 — thiotepa, 70121-2749 — thiotepa, 71288-156 — Thiotepa, 71288-157 — Thiotepa, 72205-045 — Thiotepa, 81927-105 — thiotepa, 81927-106 — thiotepa

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.